title: Predicting impaired extinction of traumatic memory and elevated startle.
abstract: BACKGROUND
  Emotionally traumatic experiences can lead to debilitating anxiety disorders, such as phobias and Post-Traumatic Stress Disorder (PTSD). Exposure to such experiences, however, is not sufficient to induce pathology, as only up to one quarter of people exposed to such events develop PTSD. These statistics, combined with findings that smaller hippocampal size prior to the trauma is associated with higher risk of developing PTSD, suggest that there are pre-disposing factors for such pathology. Because prospective studies in humans are limited and costly, investigating such pre-dispositions, and thus advancing understanding of the genesis of such pathologies, requires the use of animal models where predispositions are identified before the emotional trauma. Most existing animal models are retrospective: they classify subjects as those with or without a PTSD-like phenotype long after experiencing a traumatic event. Attempts to create prospective animal models have been largely unsuccessful.
  
  
  RESULTS
  Here we report that individual predispositions to a PTSD-like phenotype, consisting of impaired rate and magnitude of extinction of an emotionally traumatic event coupled with long-lasting elevation of acoustic startle responses, can be revealed following exposure to a mild stressor, but before experiencing emotional trauma. We compare, in rats, the utility of several classification criteria and report that a combination of criteria based on acoustic startle responses and behavior in an anxiogenic environment is a reliable predictor of a PTSD-like phenotype.
  
  
  CONCLUSIONS
  There are individual predispositions to developing impaired extinction and elevated acoustic startle that can be identified after exposure to a mildly stressful event, which by itself does not induce such a behavioral phenotype. The model presented here is a valuable tool for studying the etiology and pathophysiology of anxiety disorders and provides a platform for testing behavioral and pharmacological interventions that can reduce the probability of developing pathologic behaviors associated with such disorders.
authors: Brain and Behavior Discovery Institute and Department of Neurology, Georgia Health Sciences University, Augusta, Georgia, United States of America.
authors: Rebecca
authors: R
authors: Nalloor
authors: Kristopher
authors: K
authors: Bunting
authors: Almira
authors: A
authors: Vazdarjanova
references: Curr Protoc Neurosci. 2005 Feb;Chapter 8:Unit 8.19
references: 18428625
references: Neurosci Biobehav Rev. 2006;30(3):356-75
references: 16115684
references: Biol Psychiatry. 2009 Dec 15;66(12):1075-82
references: 19748076
references: Pharmacol Biochem Behav. 1996 May;54(1):31-40
references: 8728536
references: Psychopharmacology (Berl). 1993;111(4):491-4
references: 7870992
references: Biol Psychiatry. 1993 Apr 1;33(7):479-86
references: 8513032
references: Pharmacol Biochem Behav. 1993 Feb;44(2):463-9
references: 8446680
references: Biol Psychiatry. 2009 Mar 15;65(6):455-63
references: 18986648
references: Ann N Y Acad Sci. 2006 Jul;1071:324-34
references: 16891581
references: Ann N Y Acad Sci. 2006 Jul;1071:335-50
references: 16891582
references: Eur J Pharmacol. 2004 Nov 3;504(1-2):79-96
references: 15507224
references: Eur J Pharmacol. 2004 Nov 3;504(1-2):65-77
references: 15507223
references: Psychopharmacology (Berl). 1987;92(2):180-5
references: 3110839
references: Neurosci Biobehav Rev. 2008 Sep;32(7):1287-92
references: 18550167
references: Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 1;35(6):1357-75
references: 21129431
references: Eur J Neurosci. 2001 Aug;14(4):709-18
references: 11556895
references: Ann N Y Acad Sci. 2004 Dec;1032:167-78
references: 15677404
references: Behav Cogn Neurosci Rev. 2004 Mar;3(1):23-41
references: 15191640
references: Int J Neuropsychopharmacol. 2007 Dec;10(6):741-58
references: 17291374
references: J Nerv Ment Dis. 2007 Dec;195(12):1004-12
references: 18091194
references: Neuroscience. 2010 Aug 25;169(2):733-42
references: 20478366
references: Physiol Behav. 2006 Jun 15;88(1-2):12-29
references: 16624347
references: Psychoneuroendocrinology. 2008 Apr;33(3):282-91
references: 18164825
references: Neuron. 2007 Oct 4;56(1):19-32
references: 17920012
references: Stress. 2008 Jul;11(4):259-81
references: 18574787
references: Physiol Behav. 1993 Jul;54(1):101-9
references: 8327588
references: Eur Neuropsychopharmacol. 2008 Feb;18(2):107-16
references: 17611082
references: J Trauma Stress. 2006 Oct;19(5):571-81
references: 17075906
references: J Psychiatr Res. 2011 Jul;45(7):919-26
references: 21306736
references: J Psychiatr Res. 2008 Jun;42(7):515-20
references: 18313695
references: J Trauma Stress. 2007 Aug;20(4):413-22
references: 17721971
references: Psychopharmacology (Berl). 1994 Jan;113(3-4):570-2
references: 7862878
references: Neurosci Biobehav Rev. 1998;23(2):301-18
references: 9884124